STOCK TITAN

PepGen (PEPG) director receives 34,000 stock options grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PepGen Inc. director Heidi Henson received a grant of stock options covering 34,000 shares of common stock. The options have an exercise price of $1.79 per share and expire on June 17, 2036.

These options vest in full on the earlier of the first anniversary of the grant date or the next Annual Meeting, subject to continued service on the board unless the board determines otherwise.

Positive

  • None.

Negative

  • None.
Insider HENSON HEIDI
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 34,000 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 34,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 34,000 options Stock Option (Right to Buy) grant to director
Exercise price $1.79 per share Conversion or exercise price of options
Expiration date June 17, 2036 Option term end date
Total options after grant 34,000 options Holdings following transaction, direct ownership
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.7900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-17T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Annual Meeting financial
"earlier of the first anniversary of the date of grant or (ii) the date of the next Annual Meeting"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HENSON HEIDI

(Last)(First)(Middle)
C/O PEPGEN INC.
321 HARRISON AVE 8TH FLOOR

(Street)
BOSTON MASSACHUSETTS 02118

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PepGen Inc. [ PEPG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$1.7906/18/2026A34,000 (1)06/17/2036Common Stock34,000$034,000D
Explanation of Responses:
1. This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.
/s/ Noel Donnelly, as attorney-in-fact06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did PepGen (PEPG) director Heidi Henson report in this Form 4?

Heidi Henson reported receiving a grant of stock options for 34,000 shares of PepGen common stock at an exercise price of $1.79 per share, expiring June 17, 2036, as part of her director compensation package.

What are the key terms of Heidi Henson’s PepGen stock option grant?

The grant covers 34,000 shares of PepGen common stock with an exercise price of $1.79 per share. The options expire on June 17, 2036, giving long-term potential value if the share price exceeds the exercise price.

How do Heidi Henson’s PepGen stock options vest?

The options vest in full on the earlier of the first anniversary of the grant date or the date of the next Annual Meeting. Vesting continues only while she serves as a director, unless the board decides circumstances justify continued vesting.

How many PepGen options does Heidi Henson hold after this transaction?

After this transaction, Heidi Henson holds 34,000 stock options directly. These options give her the right to buy an equal number of PepGen common shares at $1.79 per share if they become vested and she chooses to exercise them.

Is Heidi Henson’s PepGen Form 4 transaction a market purchase or sale?

No, this Form 4 reflects a compensation-related grant, not a market trade. The stock options were awarded with a $1.79 exercise price and no cash purchase or sale of common shares occurred in the market as part of this transaction.